<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-antibodies-09-00020">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Desheva</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sychev</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Smolonogina</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Rekstin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ilyushina</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Lugovtsev</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Go</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lerner</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals</article-title>
  <source>PLoS ONE</source>
  <year>2018</year>
  <volume>13</volume>
  <elocation-id>e0196771</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0196771</pub-id>
  <pub-id pub-id-type="pmid">29742168</pub-id>
 </element-citation>
</ref>
